DXCM Q4 2021 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q4 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$698M+22.7% YoY

Gross Profit

$473M67.7% margin

Operating Income

$600,0000.1% margin

Net Income

-$19M-2.8% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+7.4%

Cash Flow

Operating Cash Flow

$106M

Free Cash Flow

$26M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$4.9B

Total Liabilities

$2.9B

Stockholders' Equity

$2.0B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$698M	$569M	+22.7%
Gross Profit	$473M	$399M	+18.4%
Operating Income	$600,000	$104M	-99.4%
Net Income	-$19M	$355M	-105.5%

Geographic Segments

UNITED STATES

$517M74%

Non-US

$181M26%